MedTrace Logo

Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers

NCT03246581 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-12-04

No results posted yet for this study

Summary

The purpose of this study is to compare the absorption of a test inhalation product with the reference product in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

Tiotropium

inhalation

Sponsors & Collaborators

  • Simbec Research

    collaborator INDUSTRY

  • 3M

    collaborator INDUSTRY

  • Kindeva Drug Delivery

    lead INDUSTRY

Principal Investigators

  • Victoria Sessions, PhD · 3M

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-13
Primary Completion
2018-01-21
Completion
2018-05-03

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03246581 on ClinicalTrials.gov